Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray

Yang Liu1, Hui Peng, Jian-Ting Zhang

  • 1IU Cancer Center, Indiana University School of Medicine, 1044 W. Walnut Street, R4-166, Indianapolis, IN 46202, USA.

Insights

Multidrug resistance (MDR) in cancer involves more than just ABCG2. This study found other ATP-binding cassette (ABC) transporters, like ABCA4 and ABCC3, also contribute to MDR in MCF7/AdVp3000 cells, suggesting new therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • ATP-binding cassette (ABC) transporters are a superfamily of membrane proteins involved in transporting various substrates.
  • Overexpression of certain human ABC transporters, such as ABCB1 and ABCC1, is linked to multidrug resistance (MDR) in cancer chemotherapy.
  • Previous research suggested ABCG2 overexpression caused MDR in the MCF7/AdVp3000 cell line, but this alone did not fully explain the observed resistance levels.

Purpose of the Study:

  • To investigate the comprehensive expression profile of ABC transporters in the multidrug-resistant MCF7/AdVp3000 cell line.
  • To identify other ABC transporters, beyond ABCG2, that may contribute to the MDR phenotype in this cell line.
  • To evaluate the utility of AmpArray analysis for profiling ABC transporter expression in resistant cell lines and tumors.

Main Methods:

  • Utilized AmpArray analysis to profile the expression of ABC transporters in MCF7/AdVp3000 cells compared to parental MCF7 cells.
  • Quantified fold-changes in expression for individual ABC transporters.
  • Performed gene silencing of ABCC3 in MCF7/AdVp3000 cells to assess its impact on doxorubicin resistance.

Main Results:

  • AmpArray analysis revealed altered expression in 16 ABC transporters in MCF7/AdVp3000 cells compared to MCF7 cells (fold-change ≥ 1.5).
  • Significant increases in expression were observed for ABCA4 (132-fold), ABCC3 (459-fold), and ABCG2 (~3000-fold).
  • Silencing ABCC3 expression in MCF7/AdVp3000 cells led to a significant reduction in doxorubicin resistance, and elevated expression of these transporters reversed with the drug resistance phenotype.

Conclusions:

  • Multidrug resistance in MCF7/AdVp3000 cells is likely mediated by the concerted action of multiple ABC transporters, including ABCA4 and ABCC3, in addition to ABCG2.
  • The findings suggest that targeting multiple ABC transporters may be a viable strategy for overcoming MDR in cancer.
  • AmpArray analysis is presented as an efficient tool for profiling ABC transporter expression, aiding in the potential for individualized cancer therapy design.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...